retatrutide for type 2 diabetes ESC 2024: improves lipid and cardiovascular risk profile in Phase II trial Retatrutide – The New Weight

If this pattern is bothersome or significantly impacts your eating habits, discuss it with your provider

Phase 4: Therapeutic dose (Weeks 13-16) Dose: 8 mg or 9 mg once weekly What to expect: Strong appetite suppression Significant ongoing weight loss Possible temporary GI flare during escalation Many reach 10-15% weight loss by this phase Tips: This is where most people stabilize 8 mg may be sufficient for manyhigher isn't always better Continue lifestyle optimization Regular check-ins with healthcare provider Phase 5: Maximum dose (Week 17+) Dose: 12 mg once weekly (if tolerated and needed) What to expect: Maximum therapeutic effect Continued weight loss (averaging 20%+ by 48 weeks in trials) GI side effects may be manageable or may persist Some achieve 25-30%+ weight loss Tips: Not everyone needs to reach 12 mg Lower doses may provide sufficient results Balance efficacy with tolerability Maintenance may involve dose reduction For general peptide dosing principles, see our peptide dosage calculator guide

But besides promoting strength and muscle growth, protein plays a key role in satiety

WidemanRD , Yu IL, Webber TD, Verchere CB, Johnson JD, Cheung AT, Kieffer TJ

[1] [6] Secondly, it suppresses the release of glucagon, a hormone that raises blood glucose levels

Remember that no matter what injection site you use out of these four, the quantity of insulin that is absorbed remains the same